Clinical Trial: A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Malignant Solid Tumor
Study Type: INTERVENTIONAL
Official Title: A Phase I, Open-label, Multicenter Study of ZL-1218 as a Single Agent and as Combination Therapy With Anti-PD-1 Antibody to Evaluate the Safety, Tolerability, and Pharmacokinetics in Subjects With Adv
Brief Summary:
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of ZL-1218 as a single agent and as combination therapy in subjects with advanced solid tumor malignancies.
Read more